Physician profile
Samuel Mark Harmsen
NPI 1528297306
$735,389.38
in general payments reported to CMS, 2019-2025
12 companies · $209K in 2025
The $209K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $31K · 2021: $60K · 2022: $51K · 2023: $198K · 2024: $123K · 2025: $209K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $139K · Acquisitions: $139K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $113K · Royalty Or License: $101K · Travel and Lodging: $23K · Food and Beverage: $7,900 · Education: $6,338 · Gift: $58.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $139,175.00 |
| Acquisitions | $138,976.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $112,895.00 |
| Royalty Or License | $100,821.29 |
| Travel and Lodging | $23,450.24 |
| Food and Beverage | $7,900.49 |
| Education | $6,337.50 |
| Gift | $58.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $337,554.84 | 2019-2025 | Arthroplasty Implants Shoulder Arthroplasty & Fracture Univers, Arthroplasty Implants Anatomic Total Shoulder Eclipse, Arthrex |
| Zimmer Biomet Holdings, INC. | $223,950.32 | 2023-2025 | Tapestry, Comprehensive Shoulder System, Tricera Handpiece |
| Shoulder Innovations, INC. | $109,544.52 | 2023-2025 | Inset System |
| Encore Medical, Lp | $43,791.97 | 2019-2022 | |
| Genesis Software Innovations, LLC | $14,660.98 | 2021-2025 | |
| Goode Surgical INC | $2,742.00 | 2020 | |
| Embody, INC. | $2,314.38 | 2022 | |
| Impactortho, INC. | $675.13 | 2022-2024 | |
| Integra Lifesciences Corporation | $50.10 | 2020 | |
| Orthofix Medical, INC. | $47.85 | 2019-2024 | Physio-Stim, Accelstim |
| Stryker Corporation | $39.00 | 2021 | |
| Tactile Systems Technology INC | $18.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$696,870.17 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Harmsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.